<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101089443</journal-id>
<journal-id journal-id-type="pubmed-jr-id">30404</journal-id>
<journal-id journal-id-type="nlm-ta">Cerebellum</journal-id>
<journal-id journal-id-type="iso-abbrev">Cerebellum</journal-id>
<journal-title-group>
<journal-title>Cerebellum (London, England)</journal-title>
</journal-title-group>
<issn pub-type="ppub">1473-4222</issn>
<issn pub-type="epub">1473-4230</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27255703</article-id>
<article-id pub-id-type="pmc">5014696</article-id>
<article-id pub-id-type="doi">10.1007/s12311-016-0797-6</article-id>
<article-id pub-id-type="manuscript">NIHMS792568</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Fragile X-associated Tremor/Ataxia Syndrome (FXTAS) Motor Dysfunction Modeled in Mice</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Foote</surname>
<given-names>Molly</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Arque</surname>
<given-names>Gloria</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Berman</surname>
<given-names>Robert F.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Santos</surname>
<given-names>Mónica</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Neurological Surgery, University of California, Davis, CA USA</aff>
<aff id="A2"><label>2</label>Department of Molecular Neuroscience, Medical University of Viena, Austria</aff>
<aff id="A3"><label>3</label>Institute of Biology, Otto-von-Guericke University, Magdeburg, Germany</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Corresponding Author: <email>mmfoote@ucdavis.edu</email>, Phone: 530 – 754 – 7499, Fax number: 530-754-5125</corresp>
<fn fn-type="COI-statement" id="FN2">
<p><bold>Compliance with Ethical Standards</bold>: <bold>Conflict of Interest:</bold> The authors declare that they have no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>9</day>
<month>6</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>10</month>
<year>2017</year>
</pub-date>
<volume>15</volume>
<issue>5</issue>
<fpage>611</fpage>
<lpage>622</lpage>
<!--elocation-id from pubmed: 10.1007/s12311-016-0797-6-->
<abstract>
<p id="P1">Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late onset neurodegenerative disorder that affects some carriers of the Fragile X premutation (PM). In PM carriers there is a moderate expansion of a CGG trinucleotide sequence (55-200 repeats) in the fragile X gene (<italic>FMR1</italic>) leading to increased <italic>FMR1</italic> mRNA and small to moderate decreases in the Fragile X Mental Retardation Protein (FMRP) expression. The key symptoms of FXTAS include cerebellar gait ataxia, kinetic tremor, sensorimotor deficits, neuropsychiatric changes, and dementia. While the specific trigger(s) that cause PM carriers to progress to FXTAS pathogenesis remains elusive, the use of animal models has shed light on the underlying neurobiology of the altered pathways involved in disease development. In this review, we examine the current use of mouse models to study PM and FXTAS, focusing on recent advances in the field. Specifically we will discuss the construct, face and predictive validities of these PM mouse models, the insights into the underlying disease mechanisms and potential treatments.</p>
</abstract>
<kwd-group>
<kwd>Fragile X Premutation</kwd>
<kwd>Fragile X-associated Tremor/Ataxia Syndrome (FXTAS)</kwd>
<kwd>Fragile X mental retardation (<italic>FMR1</italic>) gene</kwd>
<kwd>mouse models</kwd>
<kwd>CGG trinucleotide repeat</kwd>
<kwd>neurodegenerative disorder</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>